|
|
B Romagnolo, T Molina, G Leroy, C Blin, A Porteux, M Thomasset, A Vandewalle, A Kahn, C Perret
J Clin Invest. 1996;
98(3):777
doi:10.1172/JCI118850
Abstract |
Full text
| PDF

U
terine leiomyomas are a major health problem for women of reproductive age. The molecular biology of these tumors is poorly understood partly because of the lack of relevant animal models. We have produced transgenic mice expressing the simian virus 40 T antigen driven by the promoter of the Calbindin-D9K (CaBP9K) gene and either -1,000 or -117 bp of regulatory sequences so as to establish in vivo, uterine smooth muscle tumor models. Six transgenic mouse lines were obtained. Leiomyomas developed in all of them, with an almost complete penetrance of the phenotype. The smooth muscle tumors arose in different parts of the female reproductive tract. Leiomyomas usually developed in the corpus of the uterus, but one mouse line developed leiomyomas in the horn of the uterus, and another in the vagina. The CaBP9K regulatory sequences directing the expression of the Tag gene possess an estradiol responsive element, and accordingly, development of the tumors was strictly under the control of estrogen. Expression of the Tag gene is not only necessary for the initiation of the tumor but also for its development and maintenance. These transgenic mouse models should be useful for studying the pathobiology of uterine leiomyomas and could be instrumental in designing new therapeutic approaches to this disease.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(8)
| Title and authors |
Publication |
Year |
An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.
Xiaohua Gao, Linda Yu, Lysandra Castro, Alicia B Moore, Tonia Hermon, Carl Bortner, Maria Sifre, Darlene Dixon
|
Toxicology Letters
|
2010 |
HMGA2 and the p19Arf-TP53-CDKN1A axis: A delicate balance in the growth of uterine leiomyomas
Dominique Nadine Markowski, Inga von Ahsen, Maliheh Hashemi Nezhad, Werner Wosniok, Burkhard Maria Helmke, Jörn Bullerdiek
|
Genes Chromosom. Cancer
|
2010 |
Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays
Minnie Malik, William H. Catherino
|
Fertility and Sterility
|
2007 |
A mouse model of uterine leiomyosarcoma.
Katerina Politi, Matthias Szabolcs, Peter Fisher, Ana Kljuic, Thomas Ludwig, Argiris Efstratiadis
|
The American Journal of Pathology
|
2004 |
Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells
Leslie C Hodges, Kevin D Houston, Deborah S Hunter, Robin Fuchs-Young, Zhiming Zhang, Richard C Wineker, Cheryl L Walker
|
Molecular and Cellular Endocrinology
|
2002 |
A model of pulmonary adenocarcinoma in transgenic mice expressing the simian virus 40 T antigen driven by the rat Calbindin-D9K (CaBP9K) promoter
Bernadette Chailley-Heu, Caroline Rambaud, Anne-Marie Barlier-Mur, Fran�oise Galateau-Salle, Christine Perret, Fr�d�rique Capron, Thierry Lacaze-Masmonteil
|
J. Pathol.
|
2001 |
Leiomyoma?do viruses play the main role?
J�rn Bullerdiek
|
Genes Chromosom. Cancer
|
1999 |
Influence of progesterone and oestrogen on growth and morphology of a transplantable rat uterine smooth muscle tumour (SMT-Y)
J. Yamate, K. Tsujino, D. Kumagai, K. Sato, Y. Tsukamoto, M. Kuwamura, T. Kotani, S. Sakuma, J. LaMarre
|
Journal of Comparative Pathology
|
1998 |
|